Project Lead
Ms Talia Clohessy
BIO
Spinal cord injuries have a significant multisystem impact on function, respiratory capacity and quality of life. Therapeutic acute intermittent hypoxia is an emerging novel therapy to aid recovery after incomplete spinal cord injuries by enhancing neuroplasticity. Functional improvements have been demonstrated in animal models, and more recently, preliminary human clinical trials have shown Therapeutic acute intermittent hypoxia combined with task-specific training to be safe, feasible and potentially beneficial. I aim to explore whether therapeutic acute intermittent hypoxia can improve respiratory and functional outcomes for people living with spinal cord injury, with potential translation to other neuromuscular populations.
- Invited young research panel speaker at the 2024 Spinal Research Institute donor engagement event
- Unimelb MDHS promotional ‘impact’ video 2023-24
- Session chair and organising committee member of the Melbourne School of Health Sciences 2024 Graduate Research Colloquium
- Austin Health ResearchFest 2024 Conference Abstract and Poster: “ Can resting lung function predict the response of a person living with motor neuron disease to a hypoxic challenge test?”
- Austin Health ReserachFest 2023 Conference Abstract and Poster: The suitability of the Hypoxico Hyp123 Altitude Generator as a low oxygen delivery method for therapeutic acute intermittent hypoxia research trials.
- CHEST 2023 (Hawaii) Poster: The suitability of the Hypoxico HYP123 altitude generator as a low oxygen delivery method for therapeutic acute intermittent hypoxia research trials. N. Sheers, T. Clohessy, D. Berlowitz.
- Third International Motor Impairment Conference 2023 (Sydeny) Poster: The suitability of the Hypoxico HYP123 altitude generator as a low oxygen delivery method for therapeutic acute intermittent hypoxia research trials. N. Sheers, T. Clohessy, D. Berlowitz. XVII Symposium on Sleep and Breathing 2023 (Auckland) Oral presentation: The suitability of the Hypoxico HYP123 altitude generator as a low oxygen delivery method for therapeutic acute intermittent hypoxia research trials. N. Sheers, T. Clohessy, D. Berlowitz.
- Can resting lung function predict the response of a person living with motor neuron disease to a Hypoxic Challenge Test? – accepted for publication in ALS-FND and awaiting finalised manuscript and DOI
- NIV@Home: a pilot randomized controlled trial of in-home noninvasive ventilation initiation compared to a single-day admission model https://doi.org/10.1080/21678421.2024.2416668
- Shortlisted for Rob Pierce Memorial prize – Austin Health Research Fest 2023